Skip to main content
. 2019 Feb 1;2(3):e115. doi: 10.1002/hsr2.115

Figure 1.

Figure 1

Patient timelines. Each bar represents an individual patient and starts at the first dose of bevacizumab received. Treatment received after first dose of bevacizumab is shown with colored bars indicating systemic therapy, circles indicating radiotherapy, and stars indicating doses of bevacizumab. Median survival was 5.4 months (range 9 d to more than 4 y)